A. Bajor

发表

Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation – a double‐blind study

M. Rudling, M. Simrén, P. Gillberg, 2011, Alimentary pharmacology & therapeutics.

Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial

M. Simrén, R. Sadik, E. Johannesson, 2011, The American Journal of Gastroenterology.

Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea

M. Simrén, H. Graffner, K. Ung, 2017, United European gastroenterology journal.

Review article: bile acid diarrhoea – pathogenesis, diagnosis and management

M. Simrén, A. Bajor, N. Mottacki, 2016, Alimentary pharmacology & therapeutics.

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS

M. Rudling, H. Törnblom, M. Simrén, 2014, Gut.

Effect of Cholestyramine on Gastrointestinal Transit in Patients with Idiopathic Bile Acid Diarrhea: A Prospective, Open-Label Study

R. Sadik, P. Stotzer, H. Abrahamsson, 2013 .

Bile acids: short and long term effects in the intestine

P. Gillberg, H. Abrahamsson, A. Bajor, 2010, Scandinavian journal of gastroenterology.

Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption

L. Öhman, M. Rudling, P. Stotzer, 2006, European journal of gastroenterology & hepatology.

Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases.

E. Björnsson, M. Simrén, A. Niklasson, 2003, Respiratory medicine.

Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.

L. Öhman, M. Magnusson, K. Ung, 2016, Journal of Crohn's & colitis.

Bile Acid Induced Diarrhoea Pathophysiological and Clinical Aspects

A. Bajor, 2008 .

Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life

O. Wikman, R. Befrits, H. Blom, 2013, Scandinavian journal of gastroenterology.

Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

J. Halfvarson, R. Löfberg, O. Grip, 2017, Alimentary pharmacology & therapeutics.

Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients

W. Whitehead, O. Palsson, H. Törnblom, 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Mo1617 Fecal Incontinence in Irritable Bowel Syndrome (IBS): Prevalence and Associated Factors in Swedish and American Patients

W. Whitehead, O. Palsson, H. Törnblom, 2016 .

CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis

L. Öhman, M. Simrén, M. Magnusson, 2013, United European gastroenterology journal.

Cultured blood T‐cell responses predict anti‐TNF therapy response in patients with ulcerative colitis

L. Öhman, K. Ung, A. Lasson, 2015, Alimentary pharmacology & therapeutics.

Biliary sphincterotomy does not relate to diarrhoea or major changes in bile acid synthesis or plasma lipids

M. Rudling, K. Ung, A. Bajor, 2009, Scandinavian journal of gastroenterology.

Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C.

L. Öhman, M. Magnusson, K. Ung, 2015, Journal of Crohn's & colitis.

Budesonide treatment is associated with increased bile acid absorption in collagenous colitis

M. Rudling, K. Ung, A. Kilander, 2006, Alimentary pharmacology & therapeutics.

Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea

M. Simrén, R. Sadik, P. Stotzer, 2015, United European gastroenterology journal.

Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy

L. Öhman, M. Magnusson, K. Ung, 2015, Scandinavian journal of gastroenterology.

The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency

P. Hellström, S. Frigstad, H. Blom, 2017, Gastroenterology research and practice.

The NIMO Scandinavian Study

P. Hellström, S. Frigstad, H. Blom, 2017 .

The Bile Acid Turnover Rate Assessed with the 75SeHCAT Test Is Stable in Chronic Diarrhoea but Slightly Decreased in Healthy Subjects After a Long Period of Time

M. Rudling, K. Ung, A. Kilander, 2008, Digestive Diseases and Sciences.

Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain

M. Åstrand, P. Funch‐jensen, M. B. Hansen, 2011, Alimentary pharmacology & therapeutics.

Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption

E. Thomas, L. Öhman, J. Bornstein, 2009, Acta physiologica.

Authors’ response: Bile acids are important in the pathophysiology of IBS

M. Rudling, H. Törnblom, M. Simrén, 2014, Gut.